Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2003

View Archived Issues

Spotlight on viral enzyme inhibitors for the treatment of chronic hepatitis B

Olprinone reduces gut mucosal injury in rabbit model of hypoxia

E-7389 analogues designed to have minimal susceptibility to P-glycoprotein-mediated drug efflux

FR-901228 induces apoptosis in primary and metastatic uveal melanoma cell lines

U. of Minnesota scientists claim new cADPR analogues for use as immunostimulants

AstraZeneca presents new MEK inhibitors in a recent patent

IOP-lowering agents prepared and tested by Alcon researchers

Novel lipase inhibitors for obesity and diabetes in early development at OSI

New NHE-3 inhibitors and their use in sleep apnea, renal failure, stroke, etc.

Taisho patents novel melanocortin MC4 receptor antagonists

Pfizer claims new 5-HT4 receptor modulators and their use in gastrointestinal disorders

Antitumor and antiinflammatory properties of synthetic triterpenoids under study at Dartmouth

Third-generation protease inhibitor active against wild-type and resistant HIV

Lead NPI-2350 (halimide) analogues with improved cytotoxic activity presented at AACR meeting

Preliminary 48-week data from CONTEXT study

CF-101 evaluated in new phase II trial for active RA

Pan-VEGFR tyrosine kinase inhibitor with antiangiogenic and antiproliferative activity

Phase II Canadian trial of MC-4232 cleared to begin

Positive phase II results for arginine deiminase in HCC support initiation of phase III trial

MBI-226 fails to meet primary endpoint in phase III trial

VNP-40101M in combination with AraC tested in new phase I trial for leukemia

La Jolla may seek accelerated approval for Riquent

Zyvox approved for diabetic foot infections

BTG licenses anxiety and depression compounds to Abiogen

FDA clears safinamide IND for Parkinson's disease

Enbrel becomes the first FDA-approved biologic for ankylosing spondylitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...